CONMED Corporation (CNMD) Balance Sheet

Total debt declined from $990.8M in 2024Q1 to $834.2M in 2026Q2, a $156.6M reduction, while equity expanded from $854.7M to $1.0B. This suggests the company is using operating cash flow to pay down debt, consistent with the prior cash flow analysis showing cumulative OCF exceeding net income. The balance sheet appears to be strengthening, though the pace is modest and may reflect a deliberate capital allocation shift toward buybacks rather than aggressive debt reduction.

The D/E ratio has consistently declined, indicating that debt reduction is a priority, but the absolute debt level remains substantial relative to equity. With cash of only $37.3M, the company's liquidity buffer is limited, and refinancing risk may exist if debt maturities are near, though the data does not specify maturity schedules. The leverage appears strategic, as the company maintains investment in operations while gradually reducing debt, but investors should monitor interest coverage and cash flow stability.

The asset mix is dominated by goodwill, which has remained stable around $800M, suggesting prior acquisitions. This concentration raises impairment risk if cash flows underperform, especially given the margin volatility seen in 2025Q3. The low PPE relative to assets implies a manufacturing model that is not capital-intensive, consistent with the low capex observed in cash flow analysis, but it also means the balance sheet's value is heavily dependent on the performance of acquired businesses.

The steady climb in retained earnings reflects cumulative net income retention, despite dividend suspensions in 2026 and a shift to buybacks. This suggests management is prioritizing internal reinvestment and shareholder returns via repurchases, which may dilute equity less than SBC. However, the equity base is still modest relative to goodwill, and any impairment could erode book value, so the quality of equity is tied to the sustainability of earnings.

The current ratio remains above 1, suggesting short-term obligations are covered, but the sharp decline from 2.18 to 1.48 warrants attention. Cash balances have fluctuated between $24.5M and $40.8M, providing a limited buffer against operational shocks. Given the company's low cash conversion cycle and stable operating cash flow, the liquidity risk appears manageable, but the thin cash position means reliance on credit lines or refinancing could be necessary if cash flows dip.